Replies to post #19907 on Intellect Neurosciences Inc. (fka ILNS)

[montanus]

To go forward with CONJUMAB technology needs adequate financial resources that's clear, e.g. the next step with Lonza to develop and produce the molecules is possible with a partner or with non dilutive capital, approx. 10 to 20 million, ALLIMO.

montanus